147 related articles for article (PubMed ID: 32289552)
1. Trends in Radiation Fractionation for Bone Metastases: A Contemporary Nationwide Analysis.
Wegner RE; Matani H; Colonias A; Price F; Fuhrer R; Abel S
Pract Radiat Oncol; 2020; 10(6):402-408. PubMed ID: 32289552
[TBL] [Abstract][Full Text] [Related]
2. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.
Chow E; Danjoux C; Wong R; Szumacher E; Franssen E; Fung K; Finkelstein J; Andersson L; Connolly R
Radiother Oncol; 2000 Sep; 56(3):305-14. PubMed ID: 10974379
[TBL] [Abstract][Full Text] [Related]
3. Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital-based analysis of patterns of care, RT fractionation scheme, and overall survival.
Fischer-Valuck BW; Baumann BC; Apicelli A; Rao YJ; Roach M; Daly M; Dans MC; White P; Contreras J; Henke L; Gay H; Michalski JM; Abraham C
Cancer Med; 2018 Sep; 7(9):4240-4250. PubMed ID: 30120817
[TBL] [Abstract][Full Text] [Related]
4. Utilization Patterns of Single-Fraction and Short-Course Radiotherapeutic Schedules in the Management of Bone Metastases.
Koduri S; Abel S; Bergin J; Fuhrer R; Beriwal S; Wegner RE
Adv Radiat Oncol; 2023; 8(3):101176. PubMed ID: 36846440
[TBL] [Abstract][Full Text] [Related]
5. Patterns of care and survival outcomes of palliative radiation for prostate cancer with bone metastases: comparison of ≤5 fractions to ≥10 fractions.
Schreiber D; Safdieh J; Becker DJ; Schwartz D
Ann Palliat Med; 2017 Jan; 6(1):55-65. PubMed ID: 28209069
[TBL] [Abstract][Full Text] [Related]
6. Contemporary Statewide Practice Pattern Assessment of the Palliative Treatment of Bone Metastasis.
Spratt DE; Mancini BR; Hayman JA; Boike T; Pierce LJ; Moran JM; Dominello MM; Fireman M; Griffith K; Jolly S;
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):462-467. PubMed ID: 29726364
[TBL] [Abstract][Full Text] [Related]
7. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?
Fairchild A; Barnes E; Ghosh S; Ben-Josef E; Roos D; Hartsell W; Holt T; Wu J; Janjan N; Chow E
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1501-10. PubMed ID: 19464820
[TBL] [Abstract][Full Text] [Related]
8. Impact of a dedicated palliative radiation oncology service on the use of single fraction and hypofractionated radiation therapy among patients with bone metastases.
Skamene S; Agarwal I; Makar M; Krishnan M; Spektor A; Hertan L; Mouw KW; Taylor A; Noveroske Philbrick S; Balboni T
Ann Palliat Med; 2018 Apr; 7(2):186-191. PubMed ID: 29307209
[TBL] [Abstract][Full Text] [Related]
9. Impact of dynamic changes to a bone metastases pathway in a large, integrated, National Cancer Institute-designated comprehensive cancer center network.
Gebhardt BJ; Rajagopalan MS; Gill BS; Heron DE; Rakfal SM; Flickinger JC; Beriwal S
Pract Radiat Oncol; 2015; 5(6):398-405. PubMed ID: 26432676
[TBL] [Abstract][Full Text] [Related]
10. Assessment of national practice for palliative radiation therapy for bone metastases suggests marked underutilization of single-fraction regimens in the United States.
Rutter CE; Yu JB; Wilson LD; Park HS
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):548-55. PubMed ID: 25542310
[TBL] [Abstract][Full Text] [Related]
11. Patterns of practice in palliative radiotherapy for painful bone metastases: a survey in Japan.
Nakamura N; Shikama N; Wada H; Harada H; Nozaki M; Nagakura H; Tago M; Oguchi M; Uchida N;
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e117-20. PubMed ID: 22381902
[TBL] [Abstract][Full Text] [Related]
12. [Radiosensitivity of bone metastases from tumors in different primary sites].
Khmelevsky EV; Bychkova NM
Vopr Onkol; 2015; 61(1):77-84. PubMed ID: 26016150
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration.
Arcangeli G; Giovinazzo G; Saracino B; D'Angelo L; Giannarelli D; Arcangeli G; Micheli A
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1119-26. PubMed ID: 9869238
[TBL] [Abstract][Full Text] [Related]
14. Review of patterns of practice and patients' preferences in the treatment of bone metastases with palliative radiotherapy.
Bradley NM; Husted J; Sey MS; Husain AF; Sinclair E; Harris K; Chow E
Support Care Cancer; 2007 Apr; 15(4):373-85. PubMed ID: 17093915
[TBL] [Abstract][Full Text] [Related]
15. Patterns of care among patients receiving radiation therapy for bone metastases at a large academic institution.
Ellsworth SG; Alcorn SR; Hales RK; McNutt TR; DeWeese TL; Smith TJ
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1100-1105. PubMed ID: 25035214
[TBL] [Abstract][Full Text] [Related]
16. Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases.
Konski A; James J; Hartsell W; Leibenhaut MH; Janjan N; Curran W; Roach M; Watkins-Bruner D
Am J Clin Oncol; 2009 Aug; 32(4):423-8. PubMed ID: 19546803
[TBL] [Abstract][Full Text] [Related]
17. National survey of radiotherapy fractionation practice in 2003.
Williams MV; James ND; Summers ET; Barrett A; Ash DV; ;
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):3-14. PubMed ID: 16477914
[TBL] [Abstract][Full Text] [Related]
18. Palliative radiation for bone metastases from hepatocellular carcinoma: practice patterns and the amount of remaining life spent receiving treatment.
Schmid RK; Johnstone CA; Robbins JR
Ann Palliat Med; 2022 Jun; 11(6):1900-1910. PubMed ID: 35144390
[TBL] [Abstract][Full Text] [Related]
19. Did the pattern of practice in the prescription of palliative radiotherapy for the treatment of uncomplicated bone metastases change between 1999 and 2005 at the rapid response radiotherapy program?
Bradley NM; Husted J; Sey MS; Sinclair E; Li KK; Husain AF; Danjoux C; Barnes EA; Tsao MN; Barbera L; Harris K; Chiu H; Doyle M; Chow E
Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):327-36. PubMed ID: 18276125
[TBL] [Abstract][Full Text] [Related]
20. [Optimal doses and timing for tele-irradiation of bone metastases in patients with life expectancy more than 3 months].
Khmelevskiĭ EV; Pan'shin GA; Dobrovol'skaia NIu; Bol'shakova SA
Vopr Onkol; 2012; 58(3):380-6. PubMed ID: 22888655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
